Advanced Medical Solutions Grp PLC
5 March 2002
For Immediate Release: 5 March 2002
Advanced Medical Solutions Group plc
Result of Extraordinary General Meeting ('EGM')
Shareholders reject requisitioned resolution
At today's EGM, shareholders of Advanced Medical Solutions Group plc ('AMS')
resoundingly rejected the resolution, proposed by a nominee of Advanced Value
Realisation Company Limited ('AVRC'), to put AMS up for sale.
Commenting on the outcome of the EGM, Dr. Geoffrey Vernon, Chairman of AMS said:
'We are pleased with this result and look forward to moving ahead with the
business.
The Board believes that the outcome is a vote of confidence in its stated
strategy to take AMS to break-even within current cash, thereby creating a solid
financial platform on which to accelerate growth.
Management will continue to forge deeper relationships with AMS' blue chip
partners and focus on the higher margin, advanced woundcare market. The Board
is confident in its ability to build a substantial, profitable company.'
- ENDS -
Contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606 863500
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com
Robert W. Baird Tel: +44 (0) 20 7488 1212
Shaun Dobson / Tim Richardson
Buchanan Communications Tel: +44 (0) 20 7466 5000
Nicola How / Fergus Mellon
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.